
| Patient data (#0000356) |
| Disease |
- |
| Reference |
United States:Salt Lake City |
| Template |
DNA |
| Technique |
SEQ |
| Remarks |
- |
| # Reported |
1 |
| Submitter |
Sean V. Tavtigian |
| Variant data |
| Allele |
Unknown |
| Reported pathogenicity |
Unknown |
| Concluded pathogenicity |
Unknown |
| Exon |
2 |
| DNA change |
c.3G>A |
| BIC DNA change |
231G>A |
| Protein change |
p.M1I |
| Posterior P |
0.981 |
| IARC Class |
4 - Likely pathogenic |
| Key Observational Reference |
Thomassen M et al., Breast Cancer Res Treat. 2012 Apr, 132(3):1009-23. |
| Prior P reference |
Vallee MP et al., Human Mutation 37: 627-639, 2016 |
| Missense analysis Prior P |
- |
| Splicing prior P |
0.02 |
| Other Prior P |
0.00 |
| Combined prior P |
0.96 |
| Segregation LR |
2.0 |
| Pathology LR |
- |
| Sum Family LR |
- |
| Co-occurrence LR |
1.07 |
| case-control LR |
- |
| Product of LRs |
2.14 |
| Comments |
Translation initiation methionine site |
|